Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zakzanis, K. K.
Right arrow Articles by Campbell, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zakzanis, K. K.
Right arrow Articles by Campbell, Z.
Related Collections
Right arrow Neuropsychological assessment
Right arrow Other toxicology
Right arrow Cohort studies
Right arrow Natural history studies (prognosis)
Right arrowRelated Article
NEUROLOGY 2006;66:740-741
© 2006 American Academy of Neurology


Brief Communications

Memory impairment in now abstinent MDMA users and continued users: A longitudinal follow-up

Konstantine K. Zakzanis, PhD and Zachariah Campbell, MA

From the Department of Life Sciences, University of Toronto at Scarborough.

Address correspondence and reprint requests to Konstantine K. Zakzanis, PhD, University of Toronto at Scarborough, Department of Life Sciences (Neuroscience), 1265 Military Trail, Toronto, Ontario, Canada; e-mail: zakzanis{at}utsc.utoronto.ca

The authors further investigated the functional consequences of continued neurotoxicity of (±)3,4-methylenedioxymethamphetamine (MDMA) use. Fifteen participants who were previously given a brief neuropsychological battery were tested for a third time 2 years after baseline. At 2 years, seven participants were still using MDMA, whereas eight participants had become abstinent from MDMA since 1-year testing. Current users demonstrated further declines in memory ability; former users improved on several memory measures or remained static in performance.


Disclosure: The authors report no conflicts of interest.

Received September 6, 2005. Accepted in final form November 8, 2005.


Related Article

March 14 Highlights
Neurology 2006 66: 620-621. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. L. Busceti, F. Biagioni, B. Riozzi, G. Battaglia, M. Storto, C. Cinque, G. Molinaro, R. Gradini, A. Caricasole, A. M. Canudas, et al.
Enhanced Tau Phosphorylation in the Hippocampus of Mice Treated with 3,4-Methylenedioxymethamphetamine ("Ecstasy")
J. Neurosci., March 19, 2008; 28(12): 3234 - 3245.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott, I. S. McGregor, T. M. C. Lee, A. B. Scholey, and M. J. Morgan
International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16 21 July 2006 Ecstasy/MDMA and Memory Symposium
J Psychopharmacol, November 1, 2007; 21(8): 895 - 897.
[PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
Ecstasy versus alcohol: Tolstoy and the variations of unhappiness
J Psychopharmacol, January 1, 2007; 21(1): 3 - 6.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.